Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky.
D000328:Adult; D000818:Animals; D014150:Antipsychotic Agents; D002186:Cannabinoids / Q000652:urine; D002986:Clinical Trials as Topic; D003042:Cocaine; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004357:Drug Synergism; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000209:etiology / Q000652:urine; D008875:Middle Aged; D009636:Norbornanes; D009293:Opioid-Related Disorders / Q000209:etiology; D010423:Pentazocine; D011863:Radioimmunoassay; D051381:Rats; D011933:Reagent Kits, Diagnostic; D019966:Substance-Related Disorders / Q000209:etiology*; D014309:Tripelennamine
D014150:Antipsychotic Agents; D002186:Cannabinoids; D009636:Norbornanes; D011933:Reagent Kits, Diagnostic; D014309:Tripelennamine; D003042:Cocaine; C020900:fencamfamine; D010423:Pentazocine